Immunotherapy

Leukemia/Lymphoma/Hematologic

Joint Session 01 - ASTRO-ILROG Joint Session:?Riding the Tsunami: The Role and Practice of Radiation Therapy for Hematological Malignancies in the New Era of Biologicals, Immunotherapies (Checkpoint Inhibitors and CAR-T Cells)

Experimental and Clinical Experience in Integrating Immunotherapies and Radiotherapy

Sunday, October 21
1:40 PM - 2:05 PM
Location: Room 214 C/D

Timothy Illidge, MD, PhD, FRCP, FRCR, FRCPath

Disclosure:
No relationships to disclose.

Biography:
Dr Illidge is currently Head of Division of Cancer Sciences at the University of Manchester, part of the Manchester Cancer Research Centre (MCRC) and Manchester Academic Health Sciences Centre. He completed his undergraduate degrees in London with a BSc in Biochemistry, and medicine (MB BS) based at Guy’s Hospital. He gained MRCP (1993) and trained in clinical oncology in Southampton gaining FRCR in 1997. A Cancer Research Campaign clinical training fellowship led to a PhD in radiotherapy and immunotherapy combinations at University of Southampton in 1994 and the award of Young British Oncological Association researcher of the year (1997) followed by Senior Fulbright and Winston Churchill fellowships in 1998 to work at Stanford University, California. In 1999 he returned to the UK as a CRUK Senior Clinical Research Fellow and senior lecturer at University of Southampton. In 2004 he was appointed Professor of Targeted Therapy and Oncology at University of Manchester and leads a translational research group, focusing on radiotherapy and immunotherapy combinations funded by a CRUK programme grant. He was awarded the cancer researcher of the year by university of Manchester in 2012, and subsequently the researcher of the year for the Faculty of medical and Life sciences in 2013. In 2010 was awarded FRCPath for his contributions to haematological malignancies. He chaired the UK NCRI Clinical and Translational radiotherapy group from 2010-2013. He led the Radiotherapy Related Research group of the MCRC from 2007-2016, overseeing the substantial development of academic radiotherapy at the university of Manchester based at the Christie Hospital. In 2018 he was awared the Royal College of Radiologist's Gold medal for exceptional contribution to clinical oncology.

Presentation(s):

Send Email for Timothy Illidge


Assets

Experimental and Clinical Experience in Integrating Immunotherapies and Radiotherapy



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Experimental and Clinical Experience in Integrating Immunotherapies and Radiotherapy